Streetbeat News

Stock Prices

TGL

Treasure Global (NASDAQ:TGL) reported a narrower Q1 loss of $(0.11) per share compared to $(0.26) YoY, but sales declined to $13.46M from $15.56M YoY.

Portfolio Pulse from bharat@benzinga.com

November 14, 2023 | 9:40 pm

ONTX

Onconova Therapeutics (NASDAQ:ONTX) reported Q3 earnings with an EPS loss of $(0.23), which was better than the expected $(0.29) estimate, marking a 20.69% beat and an 11.54% improvement from the previous year. However, sales of $57.00K fell short of the $70.00K estimate by 18.57%, remaining flat compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:39 pm

MGOL

MGO Global (NASDAQ:MGOL) experienced a significant increase in sales, reporting $1.47M for Q3, up from $140.19K in the same quarter last year, marking a 948.57% increase. However, the company's quarterly losses widened to $(0.17) per share, a 183.33% decrease from $(0.06) per share in the same period last year.

Portfolio Pulse from bharat@benzinga.com

November 14, 2023 | 9:38 pm

VTSI

VirTra (NASDAQ:VTSI) reported Q3 earnings of $0.15 per share, surpassing the $(0.05) estimate, marking a 400% beat and a 314.29% increase from last year's $(0.07) loss per share. Sales reached $7.56M, exceeding the $6.02M estimate by 25.61% and representing a 54.21% increase from the previous year's $4.90M.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:38 pm

DNMR

Danimer Scientific has revised its 2023 Adjusted EBITDA guidance, now expecting a range of $(40)M to $(37)M, compared to the previously anticipated low end of $(23)M to $(31)M.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:37 pm

ARCT

Arcturus Therapeutics' stock is trading higher following the release of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:37 pm

IKT

Inhibikase Therapeutics (NASDAQ:IKT) reported Q3 earnings with a loss of $(0.86) per share, surpassing the $(1.19) estimate, marking a 27.73% beat and a 20.37% improvement from last year's $(1.08) loss per share. Sales soared to $79.57K, a 991.33% increase from $7.29K in the same quarter of the previous year.

Portfolio Pulse from totan@benzinga.com

November 14, 2023 | 9:36 pm

YTEN

Yield10 Bioscience (NASDAQ:YTEN) reported Q3 earnings with an EPS of $-0.41, missing estimates by 5.13% against the expected $-0.39. Revenue declined by $111 thousand compared to the same period last year. The company's past earnings performance shows a consistent pattern of not meeting EPS estimates, with the share price remaining stable after the last earnings miss.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 9:35 pm

STRC

Sarcos Technology (NASDAQ:STRC) reported Q3 2023 earnings with an adjusted EPS of $(0.66), missing the $(0.59) estimate by 11.86%. However, sales of $1.83M exceeded the $1.20M estimate by 52.25%, despite being a 60.85% decrease from the same period last year.

Portfolio Pulse from vinayak@benzinga.com

November 14, 2023 | 9:35 pm

GVP

GSE Systems (NASDAQ:GVP) reported Q3 earnings with an EPS of $-0.07, beating estimates by 88.33% but with a revenue decline of $332 thousand from the previous year. Last quarter's EPS beat was followed by a 13.73% share price drop the next day.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 9:35 pm